- Battling site competitiveness to reduce delays on study start-up: what can you do differently to tackle these operational challenges?
- When there are immense pressures on the trial ecosystem, how can we build quality and ensure quantity in an innovative way
- Developing an optimized strategy as a small to medium-sized biotech with limited resources to stay afloat
- Discussing the importance of protocol optimization and specialized statistical support to reduce the pressure on sites and relieve bottlenecks
Chair: Susan Edelstein, PhD, SVP, Clinical Research, Ardelyx